Prachi Vilas Saner, Harshali Rajiv Tuknait, Amruta Suhas Patil, Sanskruti R Rathod
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Mifepristone, a synthetic steroid with potent antiprogestational and antiglucocorticoid activity, has established itself as a versatile pharmacological agent with significant clinical implications. Initially approved for medical termination of early pregnancy, mifepristone functions by competitively inhibiting progesterone receptors, disrupting endometrial support and promoting uterine contractility when used alongside prostaglandins. Its clinical utility, however, extends well beyond reproductive health. It is employed in cervical ripening, second-trimester abortion, and labor induction.Furthermore, mifepristone has demonstrated therapeutic potential in the management of uterine fibroids, endometriosis, and as a targeted treatment in Cushing’s syndrome by modulating glucocorticoid receptors. Emerging research also explores its role in treating hormone-sensitive malignancies, including breast and ovarian cancers. As evidence continues to grow, mifepristone represents a promising tool in both gynecological and endocrine therapy, warranting further exploration and integration into broader clinical practice.
No records found.
Jaiswal S. The Role of Artificial Intellect and Machine Learning in Techniques for Assisted Fertility. Indian Journal of Maternal-Fetal & Neonatal Medicine. 2025;12(2):45-50.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| June 11, 2025 | July 21, 2025 | December 30, 2025 |
Wednesday 17 June 2026, 08:44:18 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | June 11, 2025 |
| Accepted | July 21, 2025 |
| Published | December 30, 2025 |
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.